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Abstract
Background: Although insomnia is a sex-dimorphic disorder, there is limited knowledge about the 
association between sex hormones and insomnia. In the present study, the level of hypothalamus–
pituitary–gonadal (HPG) axis activity was investigated in patients with insomnia by measuring serum 
levels of luteinizing hormone (LH), follicle stimulating hormone (FSH), 17α-Hydroxyprogesterone, 
testosterone, progesterone, estradiol, dehydroepiandrosterone sulfate, and sex hormone-binding globulin. 
Methods: Numbers of 19 patients; including 13 females (68.40%) with paradox insomnia (32–
53 years; 43.20 ± 6.40) and 17 patients; including 8 females (47.05%) with psychophysiological 
insomnia (14–62 years; 38.40 ± 16.30) were recruited. Seventeen aged-matched normal sleeper 
consisted of 13 males (26–59 years; 40.70 ± 10) consisted of 13 males (76.50%) were also recruited as 
control group. Insomnia was diagnosed by a sleep clinician according to the International Classification 
of Sleep Disorders-Second Edition criteria and an overnight polysomnography (PSG). A volume of 5 
ml of venous blood samples were collected, prepared, and stored at 8 AM under standard condition. 
Serum levels of hormones were measured using enzyme-linked immunosorbent assay kits. Data were 
analyzed by Chi-square and ANCOVA. The associations between PSG and biochemical parameters 
were evaluated using multiple linear regression analysis. Results: There were no significant differences 
in all biochemical analyses between two insomnia subgroups (paradoxical and psychophysiological 
insomnia) and normal sleepers. Testosterone was positively related to maximum pulse transit 
time (PTT). Moreover, both LH and FSH were positively related to wake index and diastolic blood 
pressure. Conclusion: Although there were no significant differences in all HPG’s hormones between 
groups, both LH and FSH were associated with wake index and diastolic blood pressure. Moreover, 
testosterone was positively related to PTT.
Keywords: Electroencephalographic signal processing, hypothalamic–Pituitary–Gonadal axis, 
insomnia, polysomnography
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Introduction
Sleep is an essential neurophysiologic 
phenomenon that plays a critical role in 
body homeostasis.[1] Poor sleep quality and 
sleep deficiencies could affect the endocrine 
systems in a way that may disturb the 
individual health.[2-4] Insomnia as a more 
prevalent sleep disorder affect 10% of 
adults.[5] Patients with insomnia have 
difficulties in initiating and maintaining 
sleep. They also may awake early in the 
morning but inable to return to sleep. These 
problems should occur at least three times 
per week for insomnia disgnosis. This 
neurophysiologic phenomenon produces 
clinically significant impairment in social 
and occupational functioning.[6] Despite 
the significant effect on the quality of 
life, its biological base has not been fully 
understood. Both men and women follow 
two different patterns of sleep habits.[7] It 
has been well established that insomnia is a 
sex-dimorphic and female-biased disorder. 
Previous studies indicated that females are 
more susceptible to insomnia rather than 
males.[8-11] Despite this gender dependency 
of insomnia, our understanding about the 
relation between sex hormones and sleep 
quality is insufficient.
The essential effects of sex steroids on 
brain structure and function have been 
documented. Sex steroids contribute 
to development and function of the 
neural system.[12,13] Moreover, steroids 
can regulate neurotransmission and 
electrophysiological properties of neurons 
by bind to synaptic membrane receptors 
temporarily.[12] Different sex steroid 
receptors in many regions of the brain 
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mediate the role of sex hormones on brain functions.[14] 
Higher susceptibility of women to insomnia has been related 
to hormonal fluctuation resulted from the menstrual 
cycle and menopausal status.[15] The direct relationship 
between sex steroids and sleep quality has been observed 
in hormone therapy studies,[16] menopausal status,[17] and 
menstrual cycle in women.[18] In addition, the effect of 
testosterone on obstructive sleep apnea (OSA) in men 
confirm the direct relationship between sex steroids and 
sleep quality.[19] Accordingly, lower sleep  quality  is related 
to lower level of testosterone, and this relation is stronger in 
older individuals. Previous studies revealed that total sleep 
deprivation significantly reduces the levels of testosterone 
and luteinizing hormone (LH). In addition, testosterone and 
estradiol have been related to objective and subjective sleep 
quality in women aged 48–59 years.[20] Also, testosterone 
level is positively related to sleep quality and efficiency[19] 
and negatively related to sleep disorders such as OSA.[21] 
It has been reported that estrogen and progesterone could 
influence sleep characteristics. Previous studies indicated 
that the activity of hypothalamus–pituitary–gonadal (HPG) 
axis disturbed by sleep deprivation.[22,23] Moreover, there is 
also a positive association between dehydroepiandrosterone 
sulfate (DHEA-S) and subjective sleep quality.[24] However, 
objective sleep monitoring has not been used so far to 
investigate the association between the activity of HPG axis 
and sleep characteristics.[25] In addition, insomnia has been 
defined as a diverse phenomenon. Different subtypes of 
insomnia have been introduced according to subjective and 
objective sleep characteristics.[26] Considering this diversity 
for investigating the endocrinological consequences of 
sleep disorders may reveal more precise finding about 
the interaction between sleep and endocrinology. In 
general, “insomnia” as a whole term was used in HPG 
data reports; however, there are rare data on paradoxical 
insomnia, and this subtype of insomnia was not usually 
considered as a separate diagnosis in biochemical studies. 
Psychophysiological and paradoxical insomnia are 
two main subtypes of the disorder which has not been 
pathophysiologically well understood.[27] Paradoxical 
insomnia or sleep state misperception in literature is 
characterized by reports of little or no sleep over long 
periods of time despite near-normal objective sleep 
architecture. Paradoxical insomnia has been introduced 
as subjective insomnia, pseudo-insomnia, subjective 
sleepiness, and sleep hypochondriasis in the literature 
in accordance with our perception about its clinical and 
neurophysiological characteristics.[28]
Sleep state misperception is a diagnostic term adopted in 
ICSD instead of subjective insomnia complaint without 
objective findings. In ICSD-2, the paradoxical insomnia 
was used and considered as a subtype of the disorder.[26] In 
addition, psychophysiological, paradoxical, and idiopathic 
insomnia were introduced for primary insomnia by the 
American Academy of Sleep.[29] In the ICSD-3, the term 
sleep state misperception was replaced with paradoxical 
insomnia.[30] In the present study, we considered the term 
paradoxical insomnia to refer to sleep state misperception 
condition, and ICSD-2 criteria were considered for 
diagnosing and classification of participants.
Objective short sleep duration has been proposed as a 
reliable marker of the biological severity of the insomnia 
disorder. Insomnia with objective short sleep duration 
is the most severe subtype of the disorder. This type 
of insomnia activate both sympathetic system and 
hypothalamus–pituitary–adrenal [HPA] axis and elevate the 
risk of hypertension, diabetes, neurocognitive impairment, 
and mortality. In contrast, paradoxical insomnia defined as 
insomnia with normal objective sleep duration is related 
to cognitive-emotional problems and cortical arousal 
but not with activation of both sympathetic system and 
hypothalamus–pituitary–adrenal [HPA] axis as limbs of 
the stress system.[31] Pulse transit time (PTT) as a blood 
pressure marker related to autonomic nervous system 
(ANS) activity is a variable measured by polysomnography 
(PSG) procedure that may reveal association between HPG, 
stress system, and sleep disturbances. PTT is a time needed 
for receiving a pulse wave from heart to the finger as a 
photoplethysmogram (PPG) measurement site.[32]
Assuming that HPG activity may be differently affected by 
paradoxical and psychophysiological insomnia, we aimed to 
investigate the final and intermediate products of HPG system 
among a group of psychophysiological and paradox insomnia 
patients in comparison with the normal sleeper. Moreover, the 
associations between HPG activity and sleep architectures as 
well as autonomic activity were also investigated.
Materials and Methods
Participants
Participants for insomnia groups (including 
psychophysiological and paradoxical insomnia) were 
selected from patients referred to Sleep Disorders 
Research Center (SDRC) of Kermanshah University of 
Medical Sciences (KUMS) due to insomnia complaint. 
Thirty-six patients with insomnia complaint; including 
21 females (58.30%) and 15 males (41.70%) aged 
14–62 years (41 ± 12.20 years) were agreed to participate 
in this study. All patients were diagnosed by sleep clinician 
according to the International Classification of Sleep 
Disorders-Second Edition (ICSD-2)[26] criteria at SDRC. 
Seventeen aged-matched volunteers with normal sleep 
consisted of 4 females (23.50%) and 13 males (76.50%) 
aged 26–59 years (40.70 ± 10 years) were recruited from 
Kermanshah province for the study as control group. All 
women participants were in the follicular phase of the 
ovarian cycle, and they recruited for sleep analysis and 
blood sampling after ends of menses days. In addition, they 
did not have any menstrual disorders. We just recruited 
females <55 years for the exclusion of postmenopausal 
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women. Furthermore, any postmenopausal symptoms were 
considered as exclusion criteria for females.
A psychiatrist experienced in sleep medicine and PSG 
interviewed participants in both patient and control groups. 
Psychiatric disorders, chronic medical conditions,  substance 
abuse, and chronic neurological, cardiovascular, and 
respiratory disorders were considered as exclusion criteria. 
Medications with a narcotic effect were stopped for at least 2 
weeks. Other sleep disorders including circadian sleep-wake 
disorders, hypersomnias, parasomnias, and restless legs 
syndrome identified by physician’s examinations, and 
sleep-disordered breathing and periodic limb movement 
disorder identified by PSG were also excluded.
The Ethics Committee of KUMS approved the study. All 
procedures performed in the study were in accordance 
with the ethical standards of the Ethics Committee of 
KUMS and with the 1964 Helsinki declaration and its 
later amendments. Detailed written informed consent was 
obtained from all participants.
Insomnia diagnosis
The diagnosis of insomnia was based on clinical interview 
by a sleep clinician according to ICSD-2.[26] First, the 
clinician interviewed patients with insomnia complaint 
referred to SDRC. In addition, all normal sleep volunteers 
were interviewed according to ICSD-2 criteria for ruling 
out any sleep disorders. Only participants with insomnia 
in patient group and volunteers without any sleep disorder 
were selected for the second step of the study.
At the next step, all selected participants were invited to 
a whole night PSG procedure. Participants completed the 
demographic questioner and Persian version of Pittsburgh 
sleep quality index (PSQI).[33] Height and weight were 
measured by digital scales and presented as cm and kg 
respectively to calculate the body mass index (BMI). Then, 
the sleep recording was started by PSG. The diagnosis 
of insomnia in patient group and ruling out any sleep 
disorders in the control were confirmed by PSG analysis.
Subjective sleep investigation
We used PSQI to evaluate subjective sleep 
characteristics.[34] It is a self-reported questionnaire for 
the measurement of sleep quality over the past month. 
The questionnaire consists of 19 items, forming seven 
components that produce one global score. Components 
include sleep quality, sleep onset latency (SOL), total sleep 
time (TST), sleep efficiency (SE), sleep disturbances, the 
use of sleeping medication, and the daytime dysfunction. 
TST, SE, and SOL were considered for analysis in the 
present study.
Polysomnography procedure
Participants were invited to sleep laboratory of SDRC 
one day before the experiment. They advised not to have 
coffee, tea, heavy diet, and cigarette as well as snooze and 
sleep during the day of the experiment. They arrived to the 
laboratory at 9 pm. The height and weight were measured 
by an experienced technician, and the participants 
completed the questioners. Then the PSG procedure was 
explained to the subject. PSG room was standardized 
for any noise and visual stimulus based on international 
standards.[35]
All participants underwent an overnight PSG 
(SOMNOscreen plus®, Somnomedics, Germany) to dignose 
and determine the severity and type of the insomnia 
disorder. PSG were performed based on the subject’s 
usual sleeping habits, and a minimum of 7 h of sleep was 
recorded for each patient.
The guideline of the American Academy of Sleep 
Medicine was considered for PSG recording. Twenty-four 
recording electrodes were prepared, including 14 
electroencephalogram channels (C4A1, C3A2, F3, F4, 
C3, C4, A1, A2, O1, O2, F3A2, F4A1, O1A2, O2A1), 
6 electrooculogram channels (EOG1, EOG2, EOG1A1, 
EOG2A1, EOG1A2, EOG2A2), 3 electromyogram 
channels (EMG, EMG1, EMG2), and an ECG channel. 
All recordings were sampled at the rate of 256 Hz. 
Electroencephalogram (EEG) was recorded using Ag/
AgCl electrodes and 10–20 system of electrode placement. 
In addition, flow (by oronasal thermistor and nasal air 
pressure transducer), thoracic and abdominal respiratory 
effort (induction plethysmography), oximetry, and body 
position were recorded. Respiration was monitored by 
nasal pressure transducers and oronasal thermocouples. 
Continuous pulse oximetry and thoracoabdominal 
movements were also measured.
The following PSG findings introduced as normal sleep 
pattern and considered as inclusion criteria for normal 
group: (a) SOL of <15 min; (b) SE of more than 85%, and (c) 
TST of >7 h. Paradoxical insomnia was determined by the 
perception of short sleep duration and insomnia complaint 
despite near-normal objective sleep patterns.[36] Criteria  for 
diagnose of paradoxical insomnia were: (i) An objective TST 
and SE more than 6 h and  30 min and 85% respectively on 
overnight PSG; ii) Significant discrepancies between objective 
(PSG) and  subjective (self-report) sleep measures (i.e., a 
difference of 60 min or more for TST, or a difference of at 
least 15% for SE). Paradoxical insomnia was dignosed if 
chronic pattern of self-reported short sleep duration had been 
reported for at least 6 months, indicated that the symtoms 
were not associated with substance abuse and other sleep 
disorders.[29] Finally, patients with insomnia complaints that 
failed to reach the above-mentioned criteria considered as 
psychophysiological insomnia. According to PSG results, four 
males in control group were excluded due to OSA symptoms.
Among PSG data pool, TST, SE, SOL, number of 
awakening, percent of different sleep stages, sleep arousal 
index, blood oxygen saturation level (SpO2), number of 
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awakening, diastolic blood pressure, wake after sleep 
onset (WASO), and PTT were extracted and considered for 
further analysis.
SOL is a time interval between reclining in bed and the 
onset of sleep.[37] Sleep arousal is a brief awakening (at 
least 3 s) without return to consciousness characterized 
by increased EEG, muscle and heart activity.[38] Sleep 
arousal index in both rapid eye movement (REM) and 
non-REM (nREM) stage defines as a sudden interruption in 
the brain sleep pattern of EEG activity. Hence, the arousal 
index is the average number of arousals per hour.[39] Number 
of awakening is a number of transitions from sleep to 
wakefulness, lasting more than 15 s. Wake index identified 
as the number of awakening events per hour of sleep.[40,41] 
SpO2 is peripheral capillary oxygen saturation. Using pulse 
oximetry, the percentage of oxygenated hemoglobin is 
measured compared to the total amount of hemoglobin in 
the blood.[42] WASO is a total amount of time awake after 
excluding SOL.[43] PTT is a time needed for receiving a 
pulse wave from heart to the finger as a PPG measurement 
site. It has been considered as a blood pressure marker and 
related to the (ANS) activity.[32] Diastolic blood pressure 
considered as a bottom number indicates the pressure in the 
arteries when the heart rests between beats.[44]
Biochemical analysis
Next morning after PSG recordings, 5 ml of venous blood 
samples were collected at 8 AM under standard condition. 
After preparation, the serum was stored at −20°C for the 
following analyses according to the standard protocols.
Serum levels of DHEA-S (Code 5175-300; Monobind Inc.), 
sex hormone-binding globulin (SHBG) (Code 9125-300; 
Monobind Inc.), testosterone (Code 3725-300; 
Monobind Inc.), estradiol (Code 4925-300; Monobind 
Inc.), progesterone (Code 4825-300; Monobind Inc.), 
17α-Hydroxyprogesterone (17-OH) (Code 5225-300; 
Monobind Inc.), follicle stimulating hormone (FSH) (Code 
425-300; Monobind Inc.), and LH (Code 625-300; 
Monobind Inc.,) were measured by using enzyme-linked 
immunosorbent assay kits. The level of absorbance was 
read using Awareness Technology STAT FAX 2100 
Microplate Reader (Awareness Technology, USA). 
Hormones levels were calibrated according to the standard 
calibration curve. Data were presented as pg/mL for 
estradiol, nmol/L for SHBG, mlU/mL for FSH and LH, and 
ng/mL for testosterone, progesterone, DHEA, and 17-OH.
Statistical analysis
Participants were divided into paradoxical and 
psychophysiological insomnia as well as normal sleeper 
groups. Data were analyzed between groups by Chi-square 
and ANCOVA. Post hoc Tukey multiple comparisons were 
used to detect the significant differences between groups. 
Related hormones data and sleep characteristics were 
compared between three groups based on age, gender, and 
BMI set as covariates. Based on the important effect of sex 
on sex-steroids, all biochemical parameters were compared 
between groups in both male and female subgroups 
separately. Multiple linear regression analysis was used to 
evaluate the associations between PSG sleep characteristics 
and biochemical parameters considering age, gender, and 
BMI as covariates. All model assumptions were evaluated 
by residual analysis. Statistical Package for Social 
Sciences (SPSS, Inc., Chicago, IL, USA) version 16.0 was 
used for the statistical analysis.
Results
Demographic findings
We recruited 53 individuals with mean age of 
40.92 ± 11.50 years. They included numbers of 17 (31.2%) 
normal sleeper and 36 insomniac patients. According to 
clinical interview, subjective sleep data collected by PSQI 
and PSG investigation, 19 participants; including 13 females 
(68.40%) and 6 males (31.60%) were diagnosed as patients 
with paradoxical insomnia (32–53 years; 43.2 ± 6.4) 
and 17 participants; including 8 females (47.05%) and 
9 males (52.95%) were identified as psychophysiological 
insomnia patients (14–62 years old; 38.40 ± 16.30).
Demographic characteristics of three studied groups were 
demonstrated in Table 1. As indicated in the table, three 
groups were age and BMI-matched. Since there were 
significantly higher numbers of females in paradoxical and 
psychophysiological insomnia, sex was considered as a 
covariant in analysis.
Polysomnography and Pittsburgh sleep quality index 
findings
We considered subjective TST, SE, SOL and PSQI total 
score for subjective sleep characteristics. In addition, 
objective TST, SE, SOL, percentage of sleep stages, REM 
arousality, nREM arousality, wake index, and WASO 
obtained from PSG were considered for analysis. We 
considered sex, age, and BMI as covariate in all analyses. 
According to ANCOVA test results, subjective TST, SE, 
SOL, and total PSQI scores were significantly different 
between three groups (P < 0.01).
Tukey post hoc analysis indicated significantly lower 
TST in paradoxical insomnia group compared to normal 
sleepers (P < 0.01) and psychophysiological insomnia 
group (P < 0.01). SOL in paradoxical insomnia group 
was significantly higher than normal sleepers and 
psychophysiological insomnia (P < 0.01). In addition, SE 
of paradoxical insomnia group was lower than both normal 
sleepers (P < 0.01) and psychophysiological insomnia 
(P < 0.01) [Table 2].
According to ANCOVA test results, objective TST, SE, 
wake index, and WASO was significantly different between 
three-studied groups (P < 0.01). In comparison to subjective 
PSQI results, Tukey post hoc analysis test revealed 
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significantly lower objective TST among psychophysiological 
insomnia group compared to normal sleepers (P = 0.01), but 
the difference between psychophysiological and paradoxical 
insomnia groups was not significant (P = 0.07). In addition, 
psychophysiological insomnia group indicate significantly 
lower objective SE compared to normal sleepers (P < 
0.01) and paradox insomnia (P = 0.04). Objective sleep 
latency was not significantly different between three 
groups (P = 0.07). PSG wake index is significantly higher 
among psychophysiological insomniac group compared 
to normal sleepers (P = 0.01) and paradoxical insomniac 
group (P = 0.04). In addition, WASO is significantly higher 
among psychophysiological insomniac group compared to 
normal group (P < 0.01) and paradoxical insomniac group 
(P = 0.02) [Table 2].
Biochemical findings
All biochemical analyses were compared using ANCOVA 
test, after adjustment of sex, BMI, and age. Furthermore, 
the biochemical parameters were compared between 
groups in two sex subgroup separately. According to the 
test results, there were no significant differences between 
normal sleepers and two subtypes of insomnia totally and 
in male and female subgroups [Table 3].
Associations between PSG sleep structures and 
biochemical parameters were analyzed by linear regression 
model adjusted by sex, age, and BMI. According to the 
results, diastolic blood pressure significantly predict 
FSH (Coefficient = 1.29; P < 0.01), LH (Coefficient = 0.34; 
P = 0.04), and SHBG (Coefficient = 1.37; P = 0.03). 
In addition, wake index was significantly associated 
with FSH (Coefficient = 1.30; P < 0.01) and 
LH (Coefficient = 0.54; P < 0.01). Testosterone was 
predicted significantly by PTT (Coefficient = 0.31; 
P < 0.01) [Table 4].
Discussion
Sleep characteristics and sleep disorders have been 
considered as sexual dimorphic phenomena.[7,8,10,45] This 
Table 1: Demographic characteristics of the studied groups
Normal (n=17), n (%) Paradoxical insomnia (n=19), n (%) Psycophysiological insomnia (n=17), n (%) P
Age† 40.76 (10.10)a 43.26 (6.45)a 38.47 (16.36)a 0.46c
Sex 0.02b
Female 4 (23.50) 13 (68.40) 8 (47.05)
Male 13 (76.50) 6 (31.60) 9 (52.95)
BMI 26.57 (3.82)a 26.55 (3.80)a 26.97 (6.54)a 0.96c
†Mean (SD). Data compared with cANCOVA and bChi-square test. Means with the same superscript letters within a row were not 
significantly different (P>0.05). SD – Standard deviation
Table 2: Sleep structures among normal sleepers and insomnia patients
Normal (n=17) Paradoxical insomnia (n=19) Psychophysiological insomnia (n=17) P
PSQI findings
Total scores 8.21 (4.73)a 15.16 (3.62)b 12.00 (5.94)a,b <0.01
TST† (h) 5.57 (1.93)a 2.25 (2.46)b 4.60 (2.73)a <0.01
SOL (h) 0.79 (0.57)a 3.01 (1.24)b 1.39 (1.32)a <0.01
SE 74.78 (25.96)a 28.88 (20.49)b 58.28 (32.66)a <0.01
PSG findings
TST (h) 7.11 (0.44)a 6.82 (0.69)a 6.02 (1.58)b <0.01
SE 92.79 (4.32)a 88.04 (7.28)a 77.25 (19.94)b <0.01
SOL (h) 7.84 (6.60)a 9.13 (6.58)a 15.30 (26.40)a 0.07
Stage 1 (%) 32.44 (16.39)a 32.56 (16.54)a 32.60 (13.51)a 0.41
Stage 2 (%) 21.67 (9.19)a 20.21 (10.27)a 16.28 (9.33)a 0.32
Stage 3 (%) 30.65 (18.39)a 23.94 (15.12)a 19.17 (16.82)a 0.15
REM (%) 8.01 (8.30)a 11.32 (8.86)a 9.13 (9.79)a 0.81
REM arousality 20.50 (11.05)a 23.86 (12.62)a 24.31 (18.28)a 0.93
nREM arousality 24.76 (9.02)a 24.74 (6.26)a 22.99 (5.43)a 0.69
Average pulse 
transit time
305.93 (10.78)a 299.79 (17.91)a 308.24 (14.72)a 0.23
Wake index 2.02 (0.68)a 3.54 (1.92)a 8.92 (10.81)b <0.01
WASO 14.53 (4.68)a 23.36 (11.94)a 40.58 (28.32)b <0.01
†Mean (SD). Statistical analysis for the equality of the mean values among three groups was evaluated using ANCOVA adjusted by sex, age, 
and BMI (P<0.05). Means with the same superscript letters within a row were not significantly different (P>0.05). TST – Total sleep time; 
SE – Sleep efficiency; SOL – Sleep onset latency; REM – Rapid eye movement stage; nREM – non-rapid eye movement stage; WASO – Wake 
after sleep onset; SD – Standard deviation; BMI – Body mass index; PSG – Polysomnography; PSQI – Pittsburgh sleep quality index
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findings originated mainly from studies investigated 
hormone therapy,[16] menopausal status,[17] and menstrual 
cycle[18] in women. However, data about the direct effect 
of sleep architectures on hormonal changes especially 
in the context of insomnia subtype is restricted. In the 
present study, we aimed to investigate HPG axis activity 
in insomnia patients in comparison with normal sleepers 
by measuring serum levels of DHEA, SHBG, testosterone, 
estradiol, progesterone, 17-OH, FSH, LH. Moreover, 
we also investigated the associations between objective 
sleep measurements obtained by PSG and serum level of 
biochemical parameters in a multivariate regression model.
The subjective and objective sleep architectures in our study 
indicated sleep state misperception condition in paradoxical 
insomnia similar to previous findings.[46,47] Objective TST 
and SE were significantly lower in psychophysiological 
insomnia compared to both normal sleeper and paradoxical 
insomnia groups. On the other hand, wake index and 
WASO was higher among psychophysiological insomnia 
compared to the other groups. This condition supports 
the state of “insomnia without objective findings” about 
paradox insomnia as unlike subjective PSQI findings, all 
important objective sleep characteristics in this group was 
similar to normal sleepers.[46]
There were no significant differences in the levels of DHEA, 
SHBG, testosterone, estradiol, progesterone, 17-OH, FSH, 
and LH between two insomnia subgroups (paradox and 
psychophysiological) and normal sleepers. To the best of 
our knowledge, there is no previous study to investigate 
sex steroids in insomnia population. Similar to our 












Total 2.19 (0.63)a 1.92 (0.68)a 2.02 (0.65)a 0.67
Male 2.22 (0.70)a 2.01 (0.76)a 2.43 (0.47)a 0.48
Female 2.10 (0.38)a 1.87 (0.66)a 1.55 (0.48)a 0.26
SHBG
Total 44.21 (24.48)a 44.69 (26.79)a 38.96 (22.13)a 0.86
Male 40.81 (18.68)a 28.34 (10.25)a 32.23 (17.75)a 0.28
Female 55.21 (39.86)a 52.23 (28.94)a 46.52 (25.20)a 0.86
Testosterone
Total 2.89 (2.18)a 1.82 (2.38)a 1.97 (2.07)a 0.39
Male 3.68 (1.84)a 4.64 (1.99)a 3.51 (1.67)a 0.47
Female 0.29 (0.59)a 0.52 (1.03)a 0.23 (0.20)a 0.69
Estradiol
Total 21.29 (31.80)a 42.57 (69.55)a 30.35 (43.20)a 0.57
Male 13.21 (6.41)a 9.93 (13.90)a 9.02 (5.50)a 0.47
Female 47.53 (63.47)a 57.63 (79.98)a 54.33 (54.67)a 0.96
Progesterone
Total 0.407 (0.400)a 0.434 (0.316)a 0.489 (0.599)a 0.97
Male 0.46 (0.43)a 0.56 (0.34)a 0.34 (0.25)a 0.53
Female 0.21 (0.17)a 0.37 (0.29)a 0.65 (0.82)a 0.33
17-OH
Total 1.805 (0.751)a 1.469 (0.430)a 1.734 (0.592)a 0.21
Male 1.75 (0.80)a 1.71 (0.46)a 1.67 (0.57)a 0.96
Female 1.98 (0.59)a 1.35 (0.37)a 1.80 (0.63)a 0.05
FSH
Total 11.87 (14.11)a 18.54 (20.16)a 14.31 (17.38)a 0.72
Male 9.85 (5.37)a 13.18 (5.01)a 11.96 (7.16)a 0.48
Female 18.41 (29.51)a 21.00 (24.04)a 16.94 (24.82)a 0.93
LH
Total 7.77 (6.91)a 6.07 (5.37)a 7.05 (10.18)a 0.84
Male 5.96 (5.52)a 2.63 (2.04) 7.55 (10.51)a 0.43
Female 13.75 (8.37)a 7.64 (5.73)a 8.48 (10.47) 0.31
†Mean (SD). Statistical analysis for the equality of the mean values among three groups was evaluated using ANCOVA adjusted 
by sex, age, and BMI (P<0.05). Means with the same superscript letters within a row were not significantly different (P>0.05). 
DHEA-S – Dehydroepiandrosterone sulfate; SHBG – Sex hormone-binding globulin; 17-OH – 17α-Hydroxyprogesterone; FSH – Follicle 
stimulating hormone; LH – Luteinizing hormone; SD – Standard deviation; BMI – Body mass index
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results, Auyeung and his colleagues found that there is 
no association between subjective insomnia complaint 
and early morning testosterone in >65–year-old men.[48] 
Previous studies on sleep fluctuations during menstrual 
cycle and menopausal status in women have revealed that 
the levels of sex hormones are related to sleep.[17,18] We 
could not find any report that directly investigated the sex 
hormones among people with insomnia diagnosis.
We did not observe any significant differences in the level 
of biochemical parameters between normal sleepers and 
two subtypes of insomnia. This finding may useful for 
modifying some maladaptive cognition in patients with 
insomnia tend to exaggerate the disorder. As they believe 
that there must be something really wrong prevent them 
going to sleep. According to previous studies on insomnia, 
sleeplessness negatively affects aspects of physical and 
mental health; however, our results did not support this 
idea. Our findings indicated that there is no significant 
association between the levels of sex hormones and the 
occurrence of all subtypes of insomnia. This result could 
be used for reassurance about the consequence of insomnia 
and modifying maladaptive cognition among insomniac 
patients.
In another part of our results, testosterone was positively 
related to maximum PTT. Some studies considered PTT 
as a sufficient measurement for stress.[32,49] Hence, the 
association between maximum PTT and serum testosterone 
might be related to ANS activity. Both animal and human 
studies confirmed the increase of serum testosterone 
level in response to stress through subsequent activation 
of HPA axis.[50,51] Studies indicated that EEG arousal 
index is not sufficient to reveal subcortical arousal 
events responsible for modulating respiratory and blood 
pressure conditions. Therefore, PTT index is more suitable 
for indicating subcortical arousal that responsible for 
vegetative and physiological consequences in the stress 
system.[52] Investigating subcortical arousal by PTT could 
lead to more precise investigation of insomnia. EEG 
monitoring of sleep reveals important information about 
neurophysiological bases of sleep disorders by recording 
surface electrophysiological activity of cortex. Therefore, 
EEG may fail to precisely reveal the role of deep brain 
structures such as reticular activating system as an 
important arousal modulator center. PTT as an index for 
subcortical arousality may provide physiological data 
to better understanding the subcortical involvement in 
insomnia.
Both LH and FSH were positively associated with wake 
index and diastolic blood pressure. These gonadotropins 
are secreted by gonadotropic cells in the anterior pituitary 
gland. The activity of gonadotropic cells is regulated by 
gonadotropin-releasing hormone (GnRH) neurons mainly 
located in preoptic area of hypothalamus. Interaction of 
sleep with preoptic area of hypothalamus has been reported, 
so far.[53] Sleep fragmentation that revealed by wake index 
may influence the preoptic area which consequently leads 
to higher activity of gonadotropic cells and increasing of 
GnRH. Previous studies conducted on puberty participants 
indicated that LH pulses occur most frequently during 
slow-wave sleep and less frequently during periods of 
wakefulness after sleep onset,[54] but the issue has not 
been considered in adults. Our results revealed that the 
wake index was positively associated with elevated serum 
level of LH and FSH. Moreover, diastolic blood pressure 
positively affects the level of gonadotropins. This finding 
may indicate the role of the stress system on activating the 
GnRH neurons in preoptic area.
Conclusion
The subjective and objective sleep architectures indicated 
sleep state misperception condition in paradoxical insomnia. 
There were no significant differences in all biochemical 
analysis between two insomnia subgroups (paradox and 
psychophysiological) and normal sleepers. Testosterone 
was positively related to maximum PTT. Moreover, both 
LH and FSH were positively associated with wake index 
and diastolic blood pressure. Doing further experimental 
studies on larger populations are also suggested.
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